Search

Your search keyword '"Van Laake, Linda W"' showing total 370 results

Search Constraints

Start Over You searched for: Author "Van Laake, Linda W" Remove constraint Author: "Van Laake, Linda W"
370 results on '"Van Laake, Linda W"'

Search Results

1. Risk Factors and Prevalence of Dilated Cardiomyopathy in Sub-Saharan Africa: Protocol for a Systematic Review

3. Comparing Conventional Chemotherapy to Chronomodulated Chemotherapy for Cancer Treatment: Protocol for a Systematic Review

8. Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues

9. The circadian clock remains intact, but with dampened hormonal output in heart failure

10. Spatial multi-omic map of human myocardial infarction

11. Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

12. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function

13. Cardiac magnetic resonance in advanced heart failure

17. Soluble Suppression of Tumorigenicity‐2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device

23. Acute heart failure: mechanisms and pre-clinical models—a Scientific Statement of the ESC Working Group on Myocardial Function

25. Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe

30. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes

33. Animal models and animal-free innovations for cardiovascular research

34. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy

35. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology

36. PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathy

37. Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices

39. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the ESC

40. Pre-Operative SARS-CoV-2 Testing in Asymptomatic Heart Transplantation Recipients.

41. Elevated Plasma Immunoglobulin Levels Prior to Heart Transplantation Are Associated with Poor Post-Transplantation Survival

44. Processed Data 2 : Spatial multi-omic map of human myocardial infarction

49. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support

50. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

Catalog

Books, media, physical & digital resources